BenevolentAI S.A.

BAI

Equity

ISIN LU2355630455 / Valor 112417726

Euronext - Euronext Amsterdam (2024-12-23)

EUR 0.39+3.20%

BenevolentAI S.A.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

BenevolentAI S.A. is a pioneering entity in the intersection of artificial intelligence (AI) and biopharmaceuticals, focusing on the discovery and development of novel drugs. Leveraging its proprietary Benevolent Platform™, the company has successfully built a diverse pipeline of drug candidates. These candidates are distinguished by their potential to become either the best in their class or the first of their kind, indicating a significant emphasis on innovation and addressing unmet medical needs. The use of AI in drug discovery allows BenevolentAI to streamline the research process, potentially reducing the time and cost associated with bringing new therapies to market. While the company's specific therapeutic areas are not detailed in the provided source, the mention of a "rich drug pipeline" suggests a broad focus on developing treatments for a variety of diseases, positioning BenevolentAI at the forefront of technology-driven pharmaceutical research.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-51.6%1Y

-96.1%3Y

%5Y

Performance

124%1Y

158%3Y

156%5Y

Volatility